Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 AUD | 0.00% | +22.92% | +94.74% |
Apr. 24 | Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer | MT |
Apr. 04 | Clarity Pharmaceuticals Signs Supply Agreement with NorthStar Medical Radioisotopes | MT |
Business Summary
Number of employees: 41
Managers
Managers | Title | Age | Since |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
Matthew Harris
FOU | Founder | - | 09-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Shaemus Gleason
COO | Chief Operating Officer | - | 21-04-30 |
Chief Tech/Sci/R&D Officer | - | 22-09-12 | |
Ellen van Dam
CTO | Chief Tech/Sci/R&D Officer | - | 14-03-31 |
Michelle Parker
CTO | Chief Tech/Sci/R&D Officer | - | 18-05-31 |
Catherine Strong
IRC | Investor Relations Contact | - | - |
Mike Ironside
PRN | Corporate Officer/Principal | - | 20-05-31 |
General Counsel | - | 19-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 21-08-24 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Matthew Harris
FOU | Founder | - | 09-12-31 |
Alan Taylor
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 271,098,503 | 219,254,543 ( 80.88 %) | 0 | 80.88 % |
Company contact information
Clarity Pharmaceuticals Ltd.
National Innovation Centre 4 Cornwallis Street
2015, Eveleigh
+
http://www.claritypharmaceuticals.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.74% | 786M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- CU6 Stock
- Company Clarity Pharmaceuticals Ltd